Tivantinib for the treatment of hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1316376
Abstract: ABSTRACT Introduction: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide with a poor prognosis due to late diagnosis in the majority of cases. Physicians are frequently confronted with patients who… read more here.
Keywords: hepatocellular carcinoma; tivantinib treatment; treatment hepatocellular; treatment ... See more keywords